TABLE 2

Evaluation of Patients with at Least 1 PET/CT Scan Showing 18F-FDG Activity in Fat Tissue and Serial Scans

Patient no.SexAge* (y)Cancer typeJulyAugustSeptemberOctoberNovemberDecemberJanuaryFebruaryMarchAprilMayJune
1M12Lymphoma(+)(+)
2F40Ovarian(+)(+)(−)
3F42Thyroid(+)(−,−)
4F18Lymphoma(−)(−)(−)(+)(+)(−)
5M10Lymphoma(−)(+)
6F54Bile duct(−)(−)(+)
7M18Lymphoma(+)(−)(+)(−)
8M18Lymphoma(−)(+)
9F17Ovarian(−)(+)(−)
10M12Lymphoma(+,+)(+)
11F26Breast(−)(+)
12F16Lymphoma(−)(+)
  • * Age at first study.

  • (+) = study with 18F-FDG activity in fat; (−) = absence of activity in fat; (+,+) = patient with repeated studies in same month.

  • Study was performed in northern hemisphere.